The grades of 6 Health Care Providers & Services stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an “A” (“strong buy”) or “B” overall (“buy”).
This is a strong week for Quest Diagnostics Incorporated (DGX). The company’s rating climbs to B from the previous week’s C. Quest Diagnostics Incorporated provides diagnostic testing, information, and services. The company also gets A’s in operating margin growth, earnings growth, and free cash flow. For more information, get Portfolio Grader’s complete analysis of DGX stock.
Patterson Companies, Inc. (PDCO) earns a B this week, jumping up from last week’s grade of C. Patterson Companies, Inc. distributes dental products, veterinary supplies for companion pets, and rehabilitation supplies. The company also gets A’s in sales growth and earnings momentum. For more information, get Portfolio Grader’s complete analysis of PDCO stock.
Fresenius Medical Care AG & Co. KGaA Sponsored ADR’s (FMS) ratings are looking better this week, moving up to a B from last week’s C. Fresenius Medical Care AG & Co. KGaA Sponsored ADR offers kidney dialysis services and manufactures and distributes equipment and products used in the treatment of dialysis patients. For more information, get Portfolio Grader’s complete analysis of FMS stock.
HealthSouth Corporation (HLS) is seeing ratings go up from a C last week to a B this week. HealthSouth Corporation provides inpatient rehabilitative healthcare services. The company also gets A’s in sales growth, earnings growth, earnings momentum, and return on equity. For more information, get Portfolio Grader’s complete analysis of HLS stock.
Digirad Corporation (DRAD) boosts its rating from a B to a A this week. Digirad Corporation engages in the development and manufacture of medical diagnostic imaging systems for nuclear cardiology and general nuclear medicine applications primarily in the United States. The company also gets A’s in sales growth, operating margin growth, earnings growth, earnings surprise, and free cash flow. For more information, get Portfolio Grader’s complete analysis of DRAD stock.
The rating of BioScrip, Inc. (BIOS) moves up this week, rising from a C to a B. BioScrip, Inc. provides pharmacy and home health services in the United States. The company also gets A’s in earnings momentum. For more information, get Portfolio Grader’s complete analysis of BIOS stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.
